Cargando…
Epigenetic Targeting of Glioblastoma
Glioblastoma is one of the first tumors where the biological changes accompanying a single epigenetic modification, the methylation of the MGMT gene, were found to be of clinical relevance. The exploration of the epigenomic landscape of glioblastoma has allowed to identify patients carrying a diffus...
Autores principales: | Romani, Massimo, Pistillo, Maria Pia, Banelli, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198064/ https://www.ncbi.nlm.nih.gov/pubmed/30386738 http://dx.doi.org/10.3389/fonc.2018.00448 |
Ejemplares similares
-
Immune Checkpoints and Innovative Therapies in Glioblastoma
por: Romani, Massimo, et al.
Publicado: (2018) -
Environmental Epigenetics: Crossroad between Public Health, Lifestyle, and Cancer Prevention
por: Romani, Massimo, et al.
Publicado: (2015) -
Targeting of Histone Demethylases KDM5A and KDM6B Inhibits the Proliferation of Temozolomide-Resistant Glioblastoma Cells
por: Romani, Massimo, et al.
Publicado: (2019) -
MicroRNA in Glioblastoma: An Overview
por: Banelli, Barbara, et al.
Publicado: (2017) -
Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cells
por: Banelli, Barbara, et al.
Publicado: (2017)